GlassScriptPhysician profile
John R Griffin
NPI 1114933827
$3,470.66
in general payments reported to CMS, 2019-2025
7 companies · $802 in 2025
The $802 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $386 · 2022: $1,953 · 2023: $176 · 2024: $154 · 2025: $802.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $604 · Travel and Lodging: $527.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $604.21 |
| Travel and Lodging | $527.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,044.65 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $1,019.36 | 2022-2025 | |
| Sientra, INC. | $789.15 | 2021-2022 | |
| Abbvie INC. | $329.82 | 2023-2024 | |
| Biocomposites INC | $144.90 | 2025 | Stimulan |
| Pacira Pharmaceuticals Incorporated | $102.63 | 2021 | |
| Allergan, INC. | $40.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Griffin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.